US 10980758
Dosage forms and therapeutic uses of L-4-chlorokynurenine
granted A61KA61K31/198A61K9/0053
Quick answer
US patent 10980758 (Dosage forms and therapeutic uses of L-4-chlorokynurenine) held by VISTAGEN THERAPUETICS, INC. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VISTAGEN THERAPUETICS, INC.
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/198, A61K9/0053, A61P, A61P25/14